MedPath

Establishment of new amniotic fluid biomarkers that reflect the prognosis of fetal growth restriction childre

Not Applicable
Conditions
fetal growth restriction
Registration Number
JPRN-UMIN000045506
Lead Sponsor
Shiga University of Medical Science Department of Obstetrics and Gynecology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
Female
Target Recruitment
301
Inclusion Criteria

Not provided

Exclusion Criteria

abruption of placenta, prolapse of umbilical cord, non reassuring fetal status, massive genital hemorrhage due to placenta previa, uterine rupture, and other feto-maternal emergent status

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To investigate the relationship between amniotic fluid L-type fatty acid-binding protein and short-term (fetal death, placental insufficiency, transient tachypnea of the newborn, respiratory distress syndrome, artificial respiration, chronic lung disease, cerebral hemorrhage, periventricular leukomalacia, necrotizing enterocolitis, retinopathy of prematurity and neonatal death) and long-term prognosis (Cerebral palsy, short stature and developmental regression ).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath